Retraction
Hydroxychloroquine: An Essential Drug in Dermatology and Its Controversial Use in COVID-19
Paper Information
Record ID:
37954
Author(s):
Journal:
Publication Date:
November 26, 2021
Retraction Date:
November 26, 2021
(4.0 years years ago)
Subjects:
Broad Categories:
Medicine
Medicine
Institutions:
Article Type:
Publisher:
Elsevier
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1016/j.adengl.2021.11.020Additional Notes:
date of retraction unknown, html page overwrite;
Citations (2)
2
Total Citations2
Post-Retraction(100.0%)
0
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
0
Within 1 year
2
After 2+ years
851
Days since retraction (latest)
Integrative Approaches for the Diagnosis and Management of Erosive Oral Lichen Planus
Cristina Popa, Ana Maria Sciucă, Bianca-Andreea Onofrei et al. (9 authors)
Diagnostics
Open Access
Published: Mar 2024
9 citations
9 citations
851 days after retraction
Dermatologists’ and Rheumatologists’ Adherence to the Latest Recommendations for Screening of Hydroxychloroquine Retinopathy in Saudi Arabia: A Cross-Sectional Study
Asail S Alghamdi, Ghaida B AlQefari, Khalil Alduraibi et al. (8 authors)
Cureus
Open Access
Published: Mar 2024
839 days after retraction
Quick Stats
Total Citations:
2
Years Since Retraction:
4.0 years
Open Access:
Yes
Last Checked:
Jul 24, 2025